First United Bank & Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $118K | Buy |
4,895
+265
| +6% | +$6.93K | 0.03% | 182 |
|
|
2026
Q1 | $130K | Hold |
4,630
| – | – | 0.04% | 171 |
|
|
2025
Q4 | $115K | Sell |
4,630
-150
| -3% | -$3.78K | 0.04% | 173 |
|
|
2025
Q3 | $122K | Sell |
4,780
-1,300
| -21% | -$32.1K | 0.04% | 179 |
|
|
2025
Q2 | $147K | Sell |
6,080
-395
| -6% | -$9.21K | 0.05% | 159 |
|
|
2025
Q1 | $164K | Sell |
6,475
-1,450
| -18% | -$37.9K | 0.06% | 156 |
|
|
2024
Q4 | $210K | Sell |
7,925
-3,072
| -28% | -$83.3K | 0.08% | 146 |
|
|
2024
Q3 | $318K | Hold |
10,997
| – | – | 0.11% | 126 |
|
|
2024
Q2 | $308K | Sell |
10,997
-428
| -4% | -$11.8K | 0.11% | 124 |
|
|
2024
Q1 | $317K | Hold |
11,425
| – | – | 0.12% | 122 |
|
|
2023
Q4 | $329K | Buy |
11,425
+470
| +4% | +$14.2K | 0.13% | 116 |
|
|
2023
Q3 | $363K | Sell |
10,955
-225
| -2% | -$7.96K | 0.17% | 114 |
|
|
2023
Q2 | $410K | Sell |
11,180
-405
| -3% | -$15.8K | 0.18% | 108 |
|
|
2023
Q1 | $473K | Sell |
11,585
-216
| -2% | -$9.33K | 0.22% | 100 |
|
|
2022
Q4 | $605K | Sell |
11,801
-1,881
| -14% | -$90.2K | 0.3% | 78 |
|
|
2022
Q3 | $599K | Sell |
13,682
-1,125
| -8% | -$54.7K | 0.3% | 82 |
|
|
2022
Q2 | $776K | Buy |
14,807
+3,110
| +27% | +$158K | 0.36% | 76 |
|
|
2022
Q1 | $606K | Sell |
11,697
-917
| -7% | -$47.6K | 0.24% | 96 |
|
|
2021
Q4 | $745K | Buy |
12,614
+398
| +3% | +$19.7K | 0.28% | 92 |
|
|
2021
Q3 | $525K | Sell |
12,216
-100
| -0.8% | -$4.43K | 0.21% | 100 |
|
|
2021
Q2 | $482K | Buy |
12,316
+556
| +5% | +$21.6K | 0.2% | 104 |
|
|
2021
Q1 | $426K | Hold |
11,760
| – | – | 0.18% | 106 |
|
|
2020
Q4 | $433K | Buy |
11,760
+230
| +2% | +$8.44K | 0.21% | 95 |
|
|
2020
Q3 | $401K | Buy |
11,530
+99
| +0.9% | +$3.47K | 0.22% | 92 |
|
|
2020
Q2 | $355K | Sell |
11,431
-882
| -7% | -$30K | 0.21% | 93 |
|
|
2020
Q1 | $381K | Buy |
12,313
+1,006
| +9% | +$34.3K | 0.27% | 88 |
|
|
2019
Q4 | $420K | Buy |
11,307
+143
| +1% | +$5.09K | 0.24% | 97 |
|
|
2019
Q3 | $381K | Sell |
11,164
-1,102
| -9% | -$40.1K | 0.24% | 98 |
|
|
2019
Q2 | $504K | Buy |
12,266
+1,470
| +14% | +$58.4K | 0.3% | 88 |
|
|
2019
Q1 | $435K | Buy |
10,796
+1,532
| +17% | +$61.4K | 0.27% | 91 |
|
|
2018
Q4 | $384K | Sell |
9,264
-172
| -2% | -$7.14K | 0.27% | 88 |
|
|
2018
Q3 | $394K | Sell |
9,436
-738
| -7% | -$28.4K | 0.25% | 93 |
|
|
2018
Q2 | $350K | Sell |
10,174
-173
| -2% | -$5.91K | 0.23% | 92 |
|
|
2018
Q1 | $348K | Sell |
10,347
-675
| -6% | -$23.2K | 0.23% | 89 |
|
|
2017
Q4 | $379K | Buy |
11,022
+432
| +4% | +$14.7K | 0.25% | 87 |
|
|
2017
Q3 | $359K | Sell |
10,590
-223
| -2% | -$7.17K | 0.24% | 90 |
|
|
2017
Q2 | $345K | Buy |
10,813
+623
| +6% | +$19.6K | 0.23% | 92 |
|
|
2017
Q1 | $331K | Buy |
10,190
+1,515
| +17% | +$47.8K | 0.23% | 95 |
|
|
2016
Q4 | $267K | Buy |
8,675
+349
| +4% | +$10.7K | 0.2% | 94 |
|
|
2016
Q3 | $267K | Sell |
8,326
-97
| -1% | -$3.24K | 0.22% | 84 |
|
|
2016
Q2 | $281K | Buy |
8,423
+527
| +7% | +$16.8K | 0.24% | 81 |
|
|
2016
Q1 | $222K | Hold |
7,896
| – | – | 0.2% | 80 |
|
|
2015
Q4 | $242K | Buy |
7,896
+159
| +2% | +$5K | 0.22% | 84 |
|
|
2015
Q3 | $231K | Buy |
7,737
+297
| +4% | +$9.52K | 0.23% | 85 |
|
|
2015
Q2 | $237K | Sell |
7,440
-211
| -3% | -$6.88K | 0.22% | 88 |
|
|
2015
Q1 | $253K | Buy |
7,651
+424
| +6% | +$13.5K | 0.23% | 82 |
|
|
2014
Q4 | $214K | Buy |
+7,227
| New | +$207K | 0.21% | 80 |
|
Other funds holding PFE
AIM
CWP
DADC
WG
First United Bank & Trust's PFE Position: Q2 2026 in Review
First United Bank & Trust increased its Pfizer (PFE) stake by 5.7% in Q2 2026, buying an estimated $6.93K and bringing the position to 4,895 shares worth $118K. The position accounts for 0.03% of the portfolio, ranked #182.
First United Bank & Trust first reported a position in PFE in Q4 2014 and has held it in 47 quarters since. The position peaked at $776K in Q2 2022. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- First United Bank & Trust held 4,895 shares of Pfizer worth $118K as of Q2 2026.
- First United Bank & Trust bought 265 Pfizer shares in Q2 2026, an estimated $6.93K.
- Pfizer made up 0.03% of First United Bank & Trust's portfolio in Q2 2026, its #182 holding.
- First United Bank & Trust first reported a position in Pfizer in Q4 2014 and has held it in 47 quarters since.
- First United Bank & Trust's Pfizer position peaked at $776K in Q2 2022.
- 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on First United Bank & Trust's 13F filing for Q2 2026, filed 20 Jul 2026.